A nurse is teaching a client who has a new prescription for montelukast to treat asthma. Which of the following statements by the client indicates an understanding of the teaching?

A. Montelukast absorption is not significantly affected by food, so it can be taken with or without meals. Focusing on fasting administration is unnecessary and could create confusion or adherence challenges. B. Montelukast is a leukotriene receptor antagonist that reduces airway inflammation, edema, and bronchoconstriction associated with asthma. It is considered a maintenance or controller medication, meaning it must be taken daily, even when symptoms are absent, to effectively prevent asthma attacks and maintain airway stability. Regular use helps reduce the frequency and severity of asthma exacerbations. Client understanding of daily adherence is crucial for long-term asthma management. C. Montelukast is not a rescue medication and does not provide immediate relief of acute bronchospasm. Short-acting beta-agonists, such as albuterol inhalers, are required for rapid symptom relief during an asthma attack. Using montelukast for acute symptoms could delay effective treatment and increase the risk of severe respiratory compromise. D. Montelukast does not replace rescue inhalers. Clients with asthma typically require a combination of long-term controller medications (like montelukast) and rescue inhalers for breakthrough symptoms. Discontinuing or reducing rescue therapy without guidance could result in uncontrolled asthma or life-threatening attacks.